Volume 12, Issue 26 pp. 3578-3590
Full Paper

Somatostatin Receptor-Mediated Tumor-Targeting Nanocarriers Based on Octreotide-PEG Conjugated Nanographene Oxide for Combined Chemo and Photothermal Therapy

Xuyuan Zhang

Xuyuan Zhang

State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, No. 24 Tong Jia Xiang, Nanjing, 210009 China

Search for more papers by this author
Chongyin Yang

Chongyin Yang

Department of Chemical and Biomolecular Engineering, University of Maryland, College Park, MD, 20742 USA

Search for more papers by this author
Jianping Zhou

Corresponding Author

Jianping Zhou

State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, No. 24 Tong Jia Xiang, Nanjing, 210009 China

E-mail: [email protected], [email protected]Search for more papers by this author
Meirong Huo

Corresponding Author

Meirong Huo

State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, No. 24 Tong Jia Xiang, Nanjing, 210009 China

E-mail: [email protected], [email protected]Search for more papers by this author
First published: 31 May 2016
Citations: 37

Abstract

Nano-sized in vivo active targeting drug delivery systems have been developed to a high anti-tumor efficacy strategy against certain cancer-cells-specific. Graphene based nanocarriers with unique physical and chemical properties have shown significant potentials in this aspect. Here, octreotide (OCT), an efficient biotarget molecule, is conjugated to PEGylated nanographene oxide (NGO) drug carriers for the first time. The obtained NGO-PEG-OCT complex shows low toxicity and excellent stability in vivo and is able to achieve somatostatin receptor-mediated tumor-specific targeting delivery. Owing to the high loading efficiency and accurate targeting delivery of anti-cancer drug doxorubicin (DOX), our DOX loaded NGO-PEG-OCT complex offers a remarkably improved cancer-cell-specific cellular uptake, chemo-cytotoxicity, and decreased systemic toxicity compared to free DOX or NGO-PEG. More importantly, due to its strong near-infrared absorption, the NGO-PEG-OCT complex further enhances efficient photothermal ablation of tumors, delivering combined chemo and photothermal therapeutic effect against cancer cells.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.